Rhythmic Auditory Stimulation in Heart Failure Patients

The aim of this study was to investigate the acute effects of rhythmic auditory stimulation (RAS) with metronome on functional capacity, vital signs, perceived fatigue, and dyspnea in patients diagnosed with heart failure. The participants (n=40) were divided into two groups: Group 1 (n=20) and Group 2 (n=20). Group 1 underwent the classic 6-minute walk test (6MWT), followed by a one-hour break, and then the 6MWT with rhythmic auditory stimulation. Group 2 underwent the 6MWT with rhythmic auditory stimulation, followed by a one-hour break, and then the classic 6MWT. Functional capacity was assessed using the 6MWT, vital signs using a digital blood pressure monitor and pulse oximeter, fatigue level using the modified Borg scale, and fatigue and dyspnea levels using the modified Borg scale. Assessments were performed in three stages: before the test, after the test, and during recovery.

Inclusion Criteria: * Being 18 years of age or older, * Scoring 20 or higher on the Mini Mental Test (Appendix 3) for patients aged 65 and over, * Having a clinical diagnosis of heart failure, * Being under stable medical treatment, * Being at Class II or Class III according to the New York Heart Association (NYHA) functional classification, * Volunteering to participate in the study and signing the Informed Consent Form. Exclusion Criteria: * • Yürümeyi veya egzersiz testini engelleyecek düzeyde ortopedik.nörolojikveya psikiyatrik hastalık tanısı bulunanlar, * Herhangi bir işitme problemi tanısı bulunan ve işitme cihazı kullananlar, * Son 1 ay içerisinde akut miyokard enfarktüsü, kardiyojenik şok veya acil koroner revaskülarizasyon gibi akut kardiyak süreçler geçirmiş olmak.